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Biallelic genotype distributions in
papers published in Gut between
1998 and 2003: altered
conclusions after recalculating
the Hardy-Weinberg equilibrium
The Hardy-Weinberg law1–4 presents a math-
ematical statement that describes the rela-
tionship between gene frequencies and
genotype frequencies: gene frequencies at a
locus in a randomly interbreeding diploid
population and population genotype fre-
quencies remain constant from generation
to generation if mating is random and
mutation, selection, and migration do not
occur. The law states a fundamental principle
of population genetics that is approximately
true for small, and holds with increasing
exactness for large populations. Should the
frequencies be perturbed for any reason, they
will come to the expected equilibrium fre-
quencies after one generation of random
mating.
The Hardy-Weinberg law can be used for
analytical purposes. It is suitable to test the
hypothesis of panmixia and evolutionary
stasis. Moreover, it represents a null hypoth-
esis to test in genetic studies. However,
according to our personal experience, data
for Hardy-Weinberg equilibrium (HWE) cal-
culations in studied populations are not
always presented in articles with data on
the genotype distributions of biallelic poly-
morphisms of Mendelian inheritance. In this
retrospective survey, we tested in papers
published in Gut, if this important and
qualifying law was checked in studies inves-
tigating genetic polymorphisms between
1998 and April 2003.
We collected genotype distributions pub-
lished in papers in Gut from 1998 (volume
42) to 2003 (volume 52). Of 2389 total
publications, we found 69 where genetic
polymorphisms were part of the study. Of
these, those articles that fulfilled the follow-
ing criteria were selected: investigation of
biallelic genetic polymorphism with Mendel-
ian inheritance; use of healthy reference
population in the study; and availability of
genotype distribution data.
We recalculated HWE in each paper and in
each study group. For this purpose, we used
Arlequin software (http://anthropologie.uni-
ge.ch/arlequin/).5 6 The level of statistical
significance was set at p,0.05. Deviations
from HWE were further confirmed by man-
ual recalculation.
Twenty publications in Gut fulfilled the
enrolment criteria; these publications pre-
sented data on 166 genotypes. However, only
four papers (20%) reported that HWE calcu-
lations were performed and genotype distri-
bution fulfilled HW criteria. Genotype
distributions in healthy reference populations
did not fulfil HWE in two publications
(10%).7 8 In two reports, HWE was fulfilled
in controls but failed in the diseased popula-
tion and this fact was not reported.9 10 In one
publication, HWE was not fulfilled either in
the healthy reference or in the diseased
populations.11 In summary, we found 11
genotype distributions in five publications of
the studied 166 genotypes and 20 papers
where calculation of the HW law (in control
or in the investigated populations) would
provide additional information. We present
the results of HW calculations of these 11
polymorphisms in table 1.
There are several explanations why the
observed genotype frequencies may deviate
significantly from those expected by HW law
and why genotypes have different likelihoods
of being included, even when determination
of genotype was methodologically correct.
One or more of the assumptions of the model
might be incorrect, non-random mating
(inbreeding or an allele effect on the mating)
or gene flow may have occurred, or selection
operated. There could also be an error at
sampling: the studied population was not
well defined or the sample size may be too
small.12 (Interestingly, the occurrence of
HWE error was independent of the number
of patients enrolled; the size of study
populations in the affected papers ranged
between 24 and 1207.)
If the genotype distribution in the control
population misses the HWE, the results
should be treated cautiously because the
observed genotype distribution does not
represent the genotype distribution in
healthy (non-diseased) people and, therefore,
conclusions cannot be drawn for the signifi-
cance of the investigated polymorphism.
If the genotype distribution in the investi-
gated (diseased) population does not fulfil
the HWE law (while the healthy reference
population fulfils it), it might be supporting
evidence for the correlation between geno-
type and disease. Unreported or weak asso-
ciations can be detected by calculating the
HWE, even when statistically significant
differences between genotype distributions
is not present.
In conclusion, we suggest that providing
genotype distribution data together with
detailed results of HWE calculations should
be a must when results of population genetic
studies are published.
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Table 1 Genotype distributions of gene polymorphisms missing the Hardy-
Weinberg equilibrium (HWE) in studies published in Gut between 1998 (volume
42) and 2003 (volume 52)
Publication
[reference]
Gene
polymorphism Subjects
Genotype
distribution
WW/WM/MM HWE p value
1998;43:187–9.7 CTLA-4 exon 1
position 49
Controls 62/47/21 0.034
HLA DR3 negative
controls
54/36/16 0.027
2001;48:836–42.9 HFE H63D
polymorphism
haplotypes
Iron overload
patients
178/85/60 0.001
2002;50:520–4.11 Methylene
tetrahydrofolate
reductase
Controls 533/560/114 0.053
Control, 60 y, 204/229/34 0.005
Female colorectal
cancer patients
134/101/35 0.031
Colorectal cancer
stage: Dukes’ B
94/64/28 0.003
Colorectal cancer
and p53 mutation2
148/116/39 0.036
2003;52:547–51.8 CYPA1A1 exon7 Controls 122/22/5 0.012
EPXH exon 3 Controls 59/58/32 0.018
2003;52:558–62.10 NOD2 gene
1007fs variant
Crohn’s disease
patients
248/20/3 0.017
WW, number of patients with homozygosity for wild allele; WM, number of patients with
heterozygosity, MM, number of patients with homozygosity for mutant allele.
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7 Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E,
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with predisposition to coeliac disease. Gut
1998;43:187–9.
8 de Jong DJ, van der Logt EM, van Schaik A, et al.
Genetic polymorphisms in biotransformation
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2003;52:547–51.
9 Aguilar-Martinez P, Bismuth M, Picot MC, et al.
Variable phenotypic presentation of iron overload
in H63D homozygotes: are genetic modifiers the
cause? Gut 2001;48:836–42.
10 Helio T, Halme L, Lappalainen M, et al. CARD15/
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Crohn’s disease. Gut 2003;52:558–62.
11 Shannon B, Gnanasampanthan S, Beilby J, et al.
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2002;50:520–4.
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Author’s reply
Gyo¨rffy et al addressed the relevant issue of
deviation of biallelic genotype distributions
from Hardy-Weinberg equilibrium and the
interpretation of case control studies. They
identified several papers that had been
published in Gut in which the genotype
distributions of cases, controls, or both
groups deviated from Hardy-Weinberg equi-
librium. They criticised the lack of reporting
these observed deviations and they even
suggested that the conclusions drawn from
these studies should be reformulated.
We completely agree with Gyo¨rffy et al that
if the genotype distribution of the control
population deviates from Hardy-Weinberg
equilibrium, it should raise the suspicion of
selection bias or genotyping error, and the
suitability of such material for case control
studies should be rechecked.
We also share the same view with these
authors that if the genotype distribution in
the diseased population does not fulfil the
Hardy-Weinberg equilibrium, it may in fact
constitute supporting evidence for the corre-
lation between genotype and disease.
Actually, in recent literature, it has been
discussed that disease susceptibility loci
could be searched for by testing for Hardy-
Weinberg disequilibrium in a gene bank of
affected individuals.1–3
In our paper, there was a deviation of the
genotype distribution from Hardy-Weinberg
equilibrium in the diseased subjects but not
in controls. The probands were not related
and the genotyping results were controlled
for. In our patient group, homozygosity for
the NOD2 1007fs mutation was slightly
overrepresented in statistical terms, which
could serve as an additional argument for the
pathophysiological significance of this muta-
tion or may represent a simple chance
finding. In our opinion, the fact that the
genotype frequencies of only the patients
deviate from Hardy-Weinberg equilibrium
does not alter the conclusions previously
made.
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Author’s reply
Gyo¨rffy et al calculated Hardy-Weinberg
equilibrium (HWE) using data from our
paper on H63D homozygotes.1 They stated
that HWE was fulfilled in the control but not
in the patient population. We do not think
that our paper was eligible for the study of
Gyo¨rffy et al because haemochromatosis
genotypes reported in our paper do not have
a biallelic distribution. Data calculated in
their report were based on results given in
table 1 of our paper. In fact, in table 1 we
listed the genotypes obtained with two
different alleles of the HFE gene implicated
in the pathogenesis of haemochromatosis
(C282Y and H63D mutations) which have
been shown to be exclusive of each other,2
along with the normal (wild-type) allele.
Thus a total of three alleles have to be taken
into account, C282Y, H63D, and wild-type.
Therefore, HWE should have been calculated
using a multiallelic system and not a biallelic
system.
Furthermore, in table 1 of their paper,
Gyo¨rffy et al reported values used to compare
the wild-type genotype (WW), homozygotes
for the mutant allele (MM), and heterozy-
gotes (WM) in each paper. For the wild-type
allelic distribution of our paper, the authors
took into account data relative to the C282Y
mutation (homozygote (n = 178) or hetero-
zygote (n = 85)) instead of the wild-type
allele (homozygote (n = 334) or heterozy-
gotes (n = 170)). Thus the values used to
calculate the wild-type counterpart of the
H63D mutation are not correct. This incorrect
use of our results may obviously lead to
erroneous conclusions.
Currently, it is well known that the various
genotypes generated by both mutations
(C282Y homozygosity, C282Y and H63D
compound heterozygosity, and H63D homo-
zygosity) and leading to iron overload have
an incomplete penetrance.3 Our patient popu-
lation was not a random population but a
sample of patients referred for HFE analysis
because of a diagnosis of iron overload. It
would not have been surprising to found
that, in this population, HWE was not
fulfilled; abnormal genotypes were obviously
overrepresented, probably according to the
degree of penetrance of each.
In our paper, we did not verify if the HWE
was applicable but we compared statistically
the patient and control populations, which
was a random well representative sample.4
We showed that there was a significant
difference between the presence of H63D
homozygotes among patients and controls.
The statistical difference was much higher for
C282Y homozygotes and compound hetero-
zygotes, but this result was not reported as it
was beyond the scope of the paper.
In conclusion, we do not think that HWE
would have contributed to the analysis of the
patient population in our paper except to
check if the control population had been
correctly chosen.
P Aguilar-Martinez, C Thelcide, J F Schved
Laboratory of Haematology, CHU of Montpellier,
Montpellier, France
M Bismuth, G-P Pageaux, P Blanc, D Larrey
Department of Hepatogastroenterology, CHU of
Montpellier, Montpellier, France
M C Picot
Department of Epidemiology, CHU of Montpellier,
Montpellier, France
F Blanc
Department of Internal Medecine, CHU of Montpellier,
34295 Montpellier, France
Correspondence to: Dr P Aguilar-Martinez,
Laboratoire d’He´matologie, Hoˆpital Saint Eloi, 80, Av
Augustin Fliche, 34295 Montpellier Cedex 5, France;
p-martinez@chu-montpellier.fr
References
1 Aguilar-Martinez P, Bismuth M, Picot MC, et al.
Variable phenotypic presentation of iron overload
in H63D homozygotes: are genetic modifiers the
cause? Gut 2001;48:836–42.
2 Beutler E. Genetic irony beyond
haemochromatosis: clinical effects of HLA-H
mutations. Lancet 1997;349:296–7.
3 Feder JN, Gnirke A, Thomas W, et al. A novel
MHC class I-like gene is mutated in patients with
hereditary haemochromatosis. Nat Genet
1996;13:399–408.
Table 1 HFE genotype of the whole population referred for a personal or family
history of iron overload (patients) compared with a control group (controls) from
our area (1276 unselected newborns)4
HFE genotype
Patients Controls
n % n %
m1m1 178 18.4 2 0.2
m1N 141 14.6 58 4.6
m1m2 85 8.8 15 1.2
m2m2 60 6.2 36 2.8
m2N 170 17.6 345 27.0
NN 334 34.5 820 64.3
Total 968 100 1276 100
m1, C282Y; m2, H63D; N, wild-type.
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NOTICES
British Society of Gastroenterology
Paul Brown Travel Fellowships
The Paul Brown Travel Fellowships are
awarded by the Endoscopy Committee of
the BSG. They are intended to assist trainee
gastroenterologists and established consul-
tants in visits to units outside the United
Kingdom for specialist experience and train-
ing in endoscopy.
Specialist registrars who have not achieved
their CCST are expected to have the approval
of their Postgraduate Dean and their Regional
Training Director when they apply for a Travel
Fellowship. Applicants are expected to provide
confirmation that they have been accepted for
training in the unit that they wish to visit.
Successful applicants will be expected to
provide a brief written report to the Endoscopy
Committee of the outcome of their visit.
Application forms are available from the
British Society of Gastroenterology Office, 3
St Andrew’s Place, London NW1 4LB. Email:
bsg@mailbox.ulcc.ac.uk
39th Annual Meeting of the European
Association for the Study of the Liver
This meeting will be held on 15–19 April 2004
in Berlin, Germany. Further details:
Secretariat, c/o Kenes International, 17 rue
du Cendrier, PO Box 1726, CH-1211 Geneva,
Switzerland. Tel: +41 22 908 0488; fax: +41 22
732 2850; email: info@easl.ch; website:
www.easl.ch/easl2004
N Deadline for receipt of abstracts: 16
November 2003
N Deadline for early registration 10 February
2004
14th International Workshop of
Digestive Endoscopy,
Ultrasonography and Radiology
The 14th International Workshop of
Digestive Endoscopy, Ultrasonography and
Radiology will be held in Marseille on
27—28 May 2004. For further information,
please contact: Nathalie Fontant, Atelier
Phenix, 41 rue Docteur Morruci, 13006 —
Marseille (tel: (33) 04-91-37-50-83; fax:
(33) 04-91-57-15-28; e-mail: nfontant@
aphenix.com).
European Postgraduate Gastro-
surgical School (EPGS) Courses 2004
The EPGS at athe Academic Medical
Center of the University of Amsterdam
will be holding the following courses
during the year: ‘Benign Hepato-Biliary
Disorders’ will be held on 22 & 23 April
2004, ‘Endosonography live in Amsterdam’
will be held on 2, 3 & 4 June 2004, and
‘Update in Coloproctology’ will be held on
28 & 29 October 2004. For further informa-
tion, please contact: J Goedkoop (tel: (31)
8th Southeast European Symposium
of Paediatric Surgery
The 8th Southeast European Symposium of
Paediatric Surgery will focus upon ‘Infec-
tious Problems in Paediatric Surgery.’
The event will be held between 24-25
September 2004, at the University of Graz,
Austria. For further information, please
contact: Professor M E Ho¨llwarth, Depart-
ment of Paediatric Surgery, Medical
University of Graz, Austria, Auen-
bruggerplatz 34, 8036 Graz (tel: + 43 316
385 3762; fax: tel: + 43 316 385 3775;
e-mail: kinderchirurgie@uni-graz.at).
Biennial Conference of the Asian
Pacific Association for Study of the
Liver
A Biennial Conference of the Asian
Pacific Association for the Study of Liver
(APASL) will take place in New Delhi,
India, on 11–15 December 2004. The dead-
line for submission of abstracts is 30 June
2004. For further information, please con-
tact Dr S K Sarin, President APASL,
Room No. 201, Academic Block, Depart-
ment of Gastroenterology, G B Pant
Hospital, New Delhi-110002, India (tel: 91-
11-23232013; fax: 91-11-23219710; e-mail:
welcome@apaslindia2004.com; website: www.
apaslindia2004.com).
566 3926; fax: (33) 267 5594; e-mail:
j.goedkoop@amc.uva.nl; website: www.
epgs.nl).
616 PostScript
www.gutjnl.com
